Keyphrases
Doxorubicin-induced Cardiotoxicity
100%
Single nucleotide Polymorphism
50%
Genome-wide Association Study
33%
Doxorubicin
33%
Cardiotoxicity
33%
Pediatric Patients
33%
Human Induced Pluripotent Stem Cell-derived Cardiomyocytes (hiPSC-CMs)
33%
Cardioprotectant
16%
Patient's Will
16%
Primary Human Cardiomyocytes
16%
Additional Therapy
16%
Treatment Therapy
16%
Human Model
16%
Patient-specific
16%
Non-coding Sequence
16%
Adverse Drug Reaction
16%
Genetic Parameters
16%
Gene Expression
16%
Genomic Variants
16%
Candidate Gene Study
16%
Leukemia
16%
Heart Failure
16%
Molecular Mechanism
16%
Regulatory Variants
16%
Potential Drivers
16%
SLC28A3
16%
Sarcoma
16%
Statistical Correlation
16%
Lymphoma
16%
Chemotherapy Drugs
16%
Metastatic Tumor
16%
Highly Effective
16%
Medicine and Dentistry
Cardiotoxicity
100%
Doxorubicin
100%
Single Nucleotide Polymorphism
37%
Genome Wide Association Study
25%
Pediatrics Patient
25%
Cardiac Muscle Cell
25%
In Vitro
12%
Rigor
12%
Solid Malignant Neoplasm
12%
Gene Expression
12%
Leukemia
12%
Adverse Drug Reaction
12%
Connective Tissue Cancer
12%
Congestive Heart Failure
12%
Induced Pluripotent Stem Cell
12%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Cardiotoxicity
100%
Adverse Drug Reaction
12%
Leukemia
12%
Chemotherapy
12%
Rigor
12%
Solid Malignant Neoplasm
12%
Connective Tissue Cancer
12%
Congestive Heart Failure
12%